The already said they wouldn't take anything less than $60 per share, and if data for Alzheimers come back positive then its anybody's guess, maybe $80 or more.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.